Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
Exit | OMEGA THERAPEUTICS INC | $0 | – | -352,941 | -100.0% | -5.08% | – | |
PRAX | Exit | PRAXIS PRECISION MEDICINES I | $0 | – | -988,995 | -100.0% | -11.33% | – |
Exit | TURNSTONE BIOLOGICS CORP | $0 | – | -549,981 | -100.0% | -14.52% | – | |
Exit | CARIBOU BIOSCIENCES INC | $0 | – | -474,067 | -100.0% | -15.18% | – | |
Exit | ENTRADA THERAPEUTICS INC | $0 | – | -509,023 | -100.0% | -53.88% | – |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
PRAXIS PRECISION MEDICINES I | 12 | Q3 2023 | 49.0% |
PROMETHEUS BIOSCIENCES INC | 9 | Q1 2023 | 93.9% |
CARIBOU BIOSCIENCES INC | 9 | Q3 2023 | 15.7% |
OMEGA THERAPEUTICS INC | 9 | Q3 2023 | 15.4% |
ENTRADA THERAPTEUTICS INC | 8 | Q3 2023 | 60.0% |
WEWORK INC | 2 | Q1 2022 | 0.2% |
PALANTIR TECHNOLOGIES INC | 1 | Q4 2020 | 92.7% |
TURNSTONE BIOLOGICS CORP | 1 | Q3 2023 | 14.5% |
View 72 Investment Holdings, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
View 72 Investment Holdings, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.